Study period | |||
---|---|---|---|
Timepoint | Enrollment | Post-randomization (12 weeks) | Close out |
Enrollment | |||
Eligibility screen | X | ||
Informed consent | X | ||
Randomization | X | ||
Intervention | |||
PeerNaija | X | X | |
PeerNaija + | X | X | |
Assessment | |||
App orientation | X | ||
Demographics survey | X | ||
Psychological survey | X | X | X |
*Depression (PHQ-9) | X | X | X |
ART Self-Efficacy (MT SES Scale) | X | X | X |
HIV Stigma (Berger's Scale) | X | X | X |
Social Support (SPS-10) | X | X | X |
Alcohol and Substance Use (CRAFFT) | X | X | X |
Adherence assessment | X | X | X |
Visual analogue scale | X | X | X |
Medication possession ratio | X | X | X |
ACTG questionnaire | X | X | X |
App usage statistics | X | X | |
Clinical measures | X | X | |
CD4 cell count | X | X | |
HIV RNA | X | X | |
Implementation outcomes | X | X | |
Feasibility, acceptability, appropriateness surveys | X | X | |
Feedback survey | X | X |